PDA + GHK-Cu protocol: PDA: 500 mcg subcutaneous or oral, once daily GHK-Cu: Per standard dosing guidelines (varies by administration route) Duration: 4 to 8 weeks PDA + SS-31 (Elamipretide) For researchers focused on mitochondrial health and cellular energy, combining penta deca peptide arginate with SS-31 creates a protocol that addresses tissue repair from both structural and energetic perspectives
It is not a substitute for medical judgment, product labeling, or institutional protocols
The only way to ensure the integrity of your research is to use products that are within their recommended shelf life
It: Does not affect liver enzymes Has no renal toxicity Does not cause stimulant effects Does not disrupt appetite or hormones Is non-habit forming That said, always consult a qualified healthcare provider before starting any new peptide protocol
Vial route adds bacteriostatic water, U-100 insulin syringes, and alcohol swabs
Many plans cover B12 injections when documented deficiency exists or when conditions affecting absorption are present
